Galapagos (GLPG) Earnings Date & Reports

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GLPG is expected to report earnings to fall 93.00% to -18 cents per share on July 23

Q2'25

Est.

$-0.19

Q1'25

Missed

by $2.57

Q4'24

Beat

by $0.02

Q3'24

Est.

$-0.82

Q2'24

Missed

by $0.01

The last earnings report on April 23 showed earnings per share of -267 cents, missing the estimate of -9 cents. With 26.35K shares outstanding, the current market capitalization sits at 1.72B.

View a ticker or compare two or three

Compare

GLPG